BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
7/20/2017 10:12:50 AM | Browse: 1069 | Download: 2379
 |
Received |
|
2017-04-05 11:30 |
|
Peer-Review Started |
|
2017-04-10 08:24 |
 |
First Decision by Editorial Office Director |
|
|
|
Return for Revision |
|
2017-04-28 17:22 |
|
Revised |
|
2017-05-10 18:19 |
|
Publication Fee Transferred |
|
2017-06-22 09:05 |
|
Second Decision by Editor |
|
2017-06-16 13:04 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2017-06-19 09:45 |
|
Articles in Press |
|
2017-06-19 09:45 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2017-07-14 02:22 |
|
Publish the Manuscript Online |
|
2017-07-20 10:12 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2017. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Basic Study |
| Article Title |
Generation of glyceraldehyde-derived advanced glycation end-products in pancreatic cancer cells and the potential of tumor promotion
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Takanobu Takata, Tadashi Ueda, Akiko Sakasai-Sakai and Masayoshi Takeuchi |
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Grants from Japan Society for the Promotion of Science (JSPS) KAKENHI Grant |
25282029 |
| Grants from Japan Society for the Promotion of Science (JSPS) KAKENHI Grant |
26750056 |
| Grants from Japan Society for the Promotion of Science (JSPS) KAKENHI Grant |
16H01811 |
|
| Corresponding Author |
Takanobu Takata, PhD, Department of Advanced Medicine, Medical Research Institute, Kanazawa Medical University, Uchinada, Ishikawa 920-0293, Japan. takajjjj@kanazawa-med.ac.jp |
| Key Words |
Tumor promotion; Glyceraldehyde-derived advanced glycation-end products; Pancreatic ductal adenocarcinoma |
| Core Tip |
The mechanisms promoting pancreatic ductal adenocarcinoma (PDAC) in the pancreas of Type 2 diabetes mellitus patients have not yet been elucidated. We hypothesized that glyceraldehyde (GA)-derived advanced glycation-end products (GA-AGEs) promote PDAC. PANC-1 cells were treated with GA, which induced the production of intracellular GA-AGEs and cell death. The high-molecular-weight complexes of heat shock proteins were produced after GA treatment in a dose-dependent manner. GA-AGEs-bovine serum albumin promoted the proliferation of PANC-1 cells. Although intracellular GA-AGEs induce pancreatic cancer cell death, their secretion and release may promote the proliferation of other pancreatic cancer cells. |
| Publish Date |
2017-07-20 10:12 |
| Citation |
Takata T, Ueda T, Sakasai-Sakai A, Takeuchi M. Generation of glyceraldehyde-derived advanced glycation end-products in pancreatic cancer cells and the potential of tumor promotion. World J Gastroenterol 2017; 23(27): 4910-4919 |
| URL |
http://www.wjgnet.com/1007-9327/full/v23/i27/4910.htm |
| DOI |
http://dx.doi.org/10.3748/wjg.v23.i27.4910 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
